scispace - formally typeset
C

Claudia Cerella

Researcher at Seoul National University

Publications -  99
Citations -  9069

Claudia Cerella is an academic researcher from Seoul National University. The author has contributed to research in topics: Apoptosis & Programmed cell death. The author has an hindex of 36, co-authored 97 publications receiving 8238 citations. Previous affiliations of Claudia Cerella include Spanish National Research Council & University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The Role of cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies

TL;DR: The findings prompt us to analyze here the effects of a combination of COX-2 inhibitors together with different clinically used therapeutic strategies in order to further improve the efficiency of future anticancer treatments.
Journal ArticleDOI

The dual role of calcium as messenger and stressor in cell damage, death, and survival.

TL;DR: This work attempts to disentangle the two scenarios, examining on the one side, the events implicated in deregulated Ca2+ toxicity and the mechanisms through which this elicits reparative or death pathways; on the other, reviewing the role of Ca2+.
Journal ArticleDOI

Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis

TL;DR: It is shown by computer simulation that the two cysteine residues of Bax may form disulfide bridges, producing conformational changes that favor Bax translocation, providing the first evidence that Bax dimerization and translocation respond to oxidative stimuli.
Journal ArticleDOI

Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials

TL;DR: Three cardiac glycosides have been developed for treatment of cancer and were tested in a phase 1 clinical trial to determine dose limiting toxicities and maximum tolerated dose.